BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $210,000 | -16.0% | 3,887 | 0.0% | 0.02% | -10.0% |
Q2 2022 | $250,000 | -25.6% | 3,887 | -10.4% | 0.02% | -33.3% |
Q1 2022 | $336,000 | -21.7% | 4,337 | -13.4% | 0.03% | -16.7% |
Q4 2021 | $429,000 | +3.9% | 5,007 | -2.4% | 0.04% | -7.7% |
Q3 2021 | $413,000 | -21.9% | 5,132 | -21.9% | 0.04% | -20.4% |
Q2 2021 | $529,000 | -22.8% | 6,575 | -19.0% | 0.05% | -26.9% |
Q1 2021 | $685,000 | -9.3% | 8,119 | -13.8% | 0.07% | -11.8% |
Q4 2020 | $755,000 | -13.7% | 9,415 | -13.5% | 0.08% | -21.6% |
Q3 2020 | $875,000 | -18.4% | 10,884 | -12.6% | 0.10% | -21.8% |
Q2 2020 | $1,072,000 | -20.7% | 12,450 | -25.2% | 0.12% | -31.9% |
Q1 2020 | $1,351,000 | -14.2% | 16,638 | -11.7% | 0.18% | +5.8% |
Q4 2019 | $1,575,000 | -19.9% | 18,839 | -16.2% | 0.17% | -24.6% |
Q3 2019 | $1,966,000 | +7.1% | 22,475 | +0.3% | 0.23% | +7.0% |
Q2 2019 | $1,835,000 | +0.8% | 22,405 | +0.1% | 0.21% | -2.3% |
Q1 2019 | $1,820,000 | +21.3% | 22,379 | -1.8% | 0.22% | +9.0% |
Q4 2018 | $1,501,000 | -16.5% | 22,799 | -2.2% | 0.20% | -2.0% |
Q3 2018 | $1,797,000 | +5.3% | 23,309 | +0.9% | 0.20% | -1.0% |
Q2 2018 | $1,706,000 | +13.7% | 23,099 | +0.1% | 0.21% | +12.0% |
Q1 2018 | $1,501,000 | +0.9% | 23,074 | +0.2% | 0.18% | +6.4% |
Q4 2017 | $1,488,000 | +4.1% | 23,024 | +1.0% | 0.17% | 0.0% |
Q3 2017 | $1,430,000 | -2.3% | 22,790 | -5.7% | 0.17% | -1.7% |
Q2 2017 | $1,463,000 | +24.6% | 24,167 | +6.8% | 0.18% | +28.5% |
Q1 2017 | $1,174,000 | +29.2% | 22,637 | +10.5% | 0.14% | +37.0% |
Q4 2016 | $909,000 | +52.0% | 20,490 | +152.5% | 0.10% | +29.9% |
Q1 2014 | $598,000 | – | 8,115 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |